Cargando…
Potential Utility of Biased GPCR Signaling for Treatment of Psychiatric Disorders
Tremendous advances have been made recently in the identification of genes and signaling pathways associated with the risks for psychiatric disorders such as schizophrenia and bipolar disorder. However, there has been a marked reduction in the pipeline for the development of new psychiatric drugs wo...
Autores principales: | Komatsu, Hidetoshi, Fukuchi, Mamoru, Habata, Yugo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6651563/ https://www.ncbi.nlm.nih.gov/pubmed/31261897 http://dx.doi.org/10.3390/ijms20133207 |
Ejemplares similares
-
Psychiatric Neural Networks and Precision Therapeutics by Machine Learning
por: Komatsu, Hidetoshi, et al.
Publicado: (2021) -
In Silico Study of Allosteric Communication Networks in GPCR Signaling Bias
por: Morales-Pastor, Adrian, et al.
Publicado: (2022) -
Novel Therapeutic GPCRs for Psychiatric Disorders
por: Komatsu, Hidetoshi
Publicado: (2015) -
Temporal and Spatial Transcriptional Fingerprints by Antipsychotic or Propsychotic Drugs in Mouse Brain
por: Sakuma, Kensuke, et al.
Publicado: (2015) -
Fasiglifam (TAK‐875) has dual potentiating mechanisms via Gαq‐GPR40/FFAR1 signaling branches on glucose‐dependent insulin secretion
por: Sakuma, Kensuke, et al.
Publicado: (2016)